These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17242151)

  • 1. Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenases.
    Saleh A; Friesen J; Baumeister S; Gross U; Bohne W
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1217-22. PubMed ID: 17242151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II NADH dehydrogenase inhibitor 1-hydroxy-2-dodecyl-4(1H)quinolone leads to collapse of mitochondrial inner-membrane potential and ATP depletion in Toxoplasma gondii.
    Lin SS; Gross U; Bohne W
    Eukaryot Cell; 2009 Jun; 8(6):877-87. PubMed ID: 19286986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Toxoplasma gondii type-II NADH dehydrogenase TgNDH2-I is inhibited by 1-hydroxy-2-alkyl-4(1H)quinolones.
    Lin SS; Kerscher S; Saleh A; Brandt U; Gross U; Bohne W
    Biochim Biophys Acta; 2008 Nov; 1777(11):1455-62. PubMed ID: 18786503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.
    Vallières C; Fisher N; Antoine T; Al-Helal M; Stocks P; Berry NG; Lawrenson AS; Ward SA; O'Neill PM; Biagini GA; Meunier B
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3739-47. PubMed ID: 22547613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
    Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
    J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
    Hegewald J; Gross U; Bohne W
    Mol Biochem Parasitol; 2013 Jul; 190(1):6-15. PubMed ID: 23747278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum.
    Baramee A; Coppin A; Mortuaire M; Pelinski L; Tomavo S; Brocard J
    Bioorg Med Chem; 2006 Mar; 14(5):1294-302. PubMed ID: 16242338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii.
    Bajohr LL; Ma L; Platte C; Liesenfeld O; Tietze LF; Gross U; Bohne W
    Antimicrob Agents Chemother; 2010 Jan; 54(1):517-21. PubMed ID: 19884369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone), a high affinity inhibitor for mitochondrial alternative NADH dehydrogenase: evidence for a ping-pong mechanism.
    Eschemann A; Galkin A; Oettmeier W; Brandt U; Kerscher S
    J Biol Chem; 2005 Feb; 280(5):3138-42. PubMed ID: 15533932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
    Strobl JS; Seibert CW; Li Y; Nagarkatti R; Mitchell SM; Rosypal AC; Rathore D; Lindsay DS
    J Parasitol; 2009 Feb; 95(1):215-23. PubMed ID: 18837587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
    Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.
    Dong CK; Patel V; Yang JC; Dvorin JD; Duraisingh MT; Clardy J; Wirth DF
    Bioorg Med Chem Lett; 2009 Feb; 19(3):972-5. PubMed ID: 19097788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.
    Szajnman SH; Galaka T; Li ZH; Li C; Howell NM; Chao MN; Striepen B; Muralidharan V; Moreno SN; Rodriguez JB
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
    Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
    ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone-based drugs against Toxoplasma gondii and Plasmodium spp.
    Anquetin G; Greiner J; Vierling P
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):227-45. PubMed ID: 16181142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.
    McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW
    Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial quinolones: synthesis, potency, and mechanistic studies.
    Winter RW; Kelly JX; Smilkstein MJ; Dodean R; Hinrichs D; Riscoe MK
    Exp Parasitol; 2008 Apr; 118(4):487-97. PubMed ID: 18082162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance.
    McFadden DC; Tomavo S; Berry EA; Boothroyd JC
    Mol Biochem Parasitol; 2000 Apr; 108(1):1-12. PubMed ID: 10802314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.